PWMG
GSK icon

Provence Wealth Management Group’s GSK GSK Stock Holding History

Provence Wealth Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$4.34K Hold
117
– – ﹤0.01% 368
2023
Q3 		$4.24K Buy
+117
New +$4.15K ﹤0.01% 372

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Provence Wealth Management Group's GSK Position: Q4 2023 in Review

Provence Wealth Management Group held its GSK (GSK) position steady in Q4 2023 at 117 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #368.

Provence Wealth Management Group first reported a position in GSK in Q3 2023 and has held it in 2 quarters since. 896 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Provence Wealth Management Group held 117 shares of GSK worth $4.34K as of Q4 2023.
  • Provence Wealth Management Group left its GSK share count unchanged in Q4 2023.
  • GSK made up ﹤0.01% of Provence Wealth Management Group's portfolio in Q4 2023, its #368 holding.
  • Provence Wealth Management Group first reported a position in GSK in Q3 2023 and has held it in 2 quarters since.
  • 896 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.